Inspire Medical Systems Stock Price, News & Analysis (NYSE:INSP)

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 2 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" INSP shares.
View INSP analyst ratings or view top-rated stocks.

13 Wall Street analysts have issued 12 month target prices for Inspire Medical Systems' stock. Their INSP share price targets range from $159.00 to $371.00. On average, they expect the company's share price to reach $283.92 in the next year. This suggests a possible upside of 98.4% from the stock's current price.
View analysts price targets for INSP or view top-rated stocks among Wall Street analysts.

Inspire Medical Systems' stock was trading at $251.88 at the beginning of the year. Since then, INSP stock has decreased by 43.2% and is now trading at $143.09.
View the best growth stocks for 2023 here.

Inspire Medical Systems saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 1,320,000 shares, an increase of 10.0% from the October 31st total of 1,200,000 shares. Based on an average trading volume of 730,800 shares, the short-interest ratio is currently 1.8 days.
View Inspire Medical Systems' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 6th 2024.
View our INSP earnings forecast.

Inspire Medical Systems, Inc. (NYSE:INSP) released its quarterly earnings results on Tuesday, November, 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.53) by $0.24. The company had revenue of $153.30 million for the quarter, compared to analyst estimates of $154.49 million. Inspire Medical Systems had a negative net margin of 5.75% and a negative trailing twelve-month return on equity of 6.32%. Inspire Medical Systems's revenue for the quarter was up 40.4% on a year-over-year basis. During the same period in the prior year, the business earned ($0.60) earnings per share.

ETFs with the largest weight of Inspire Medical Systems (NYSE:INSP) stock in their portfolio include Harbor Health Care ETF (MEDI), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Fidelity Digital Health ETF (FDHT), Invesco Dorsey Wright Healthcare Momentum ETF (PTH), BNY Mellon Innovators ETF (BKIV), Principal Healthcare Innovators ETF (BTEC), Franklin Intelligent Machines ETF (IQM) and WisdomTree U.S. Growth & Momentum Fund (WGRO).

2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

(INSP) raised $75 million in an IPO on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Inspire Medical Systems' stock is owned by many different retail and institutional investors. Top institutional shareholders include FMR LLC (8.37%), Westfield Capital Management Co. LP (2.48%), William Blair Investment Management LLC (2.37%), Federated Hermes Inc. (1.68%), Fred Alger Management LLC (1.37%) and Bank of New York Mellon Corp (1.27%). Insiders that own company stock include Georgia Melenikiotou, Jerry C Griffin, John Rondoni, Marilyn C Nelson, Philip Ebeling, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert.
View institutional ownership trends.

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.